Clovis Oncology, Inc. - Product Pipeline Review - 2013 - New Report Available

From: Fast Market Research, Inc.
Published: Fri Aug 16 2013

Global Market Direct's pharmaceuticals report, "Clovis Oncology, Inc. - Product Pipeline Review - 2013" provides data on the Clovis Oncology, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Clovis Oncology, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Clovis Oncology, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


* Clovis Oncology, Inc. - Brief Clovis Oncology, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Clovis Oncology, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Clovis Oncology, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Clovis Oncology, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at

Reasons to Get this Report

* Evaluate Clovis Oncology, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Clovis Oncology, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Clovis Oncology, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Clovis Oncology, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Clovis Oncology, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Clovis Oncology, Inc.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Clovis Oncology, Inc. - Product Pipeline Review - 2012
- Clovis Oncology, Inc. (CLVS) - Financial and Strategic SWOT Analysis Review
- Light Sciences Oncology, Inc. - Product Pipeline Review - 2013
- Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013
- F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2013

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »